MEN1 Deficiency Drives Lung Cancer Progression via Activation of MMP10 ‐Mediated Angiogenesis
Cancer Science · 21.07.2026
DOI: 10.1111/cas.70470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 21.07.2026. Verfasst von Chengyu Wei und 17 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Anhui Medical University, Hefei, Anhui, P. R. China. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of China Youth Project, Anhui Medical University.
Abstract (Originalsprache)
Angiogenesis is essential for tumor progression, MEN1 gene encodes the menin protein, which is known as a tumor suppressor in lung tissue. Our previous study have shown that vascular density is significantly increased in menin‐deficient lung cancer, suggesting that menin deficiency may promote the malignant progression of lung cancer by enhancing angiogenesis. However, whether menin play an important role in angiogenesis of lung cancer and the underlying mechanisms remain unclear. In this study, lung‐specific Kras G12D mutation induced mouse lung cancer model, clinical human lung cancer tissues, lung cancer and vascular endothelial cell lines were utilized, RNA‐seq, ATAC‐seq, ChIP, tube formation, sprouting, invasion and migration experiments were applied to investigate the role and mechanism of MEN1 in lung cancer angiogenesis. The result show menin were negatively related to angiogenesis markers and phenotype. Menin deficiency indirectly upregulates MMP10 transcription through activation of the transcription factor JunD. The expression of MMP10 further activates the EGFR receptor in vascular endothelial cells, thereby initiating the AKT/ERK signaling pathway. Inhibition MMP10 reversed menin low expression induce angiogenic phenotype and tumor progress. In conclusion, menin deficiency promotes angiogenesis through upregulates MMP10, targeting MMP10 with inhibitor represent an effective anti‐angiogenic strategy for treating MEN1 ‐deficient lung cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Nursing, Anhui Medical University, Hefei, Anhui, P. R. China.
- The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, P. R. China.
- Department of Pathology, Zhejiang Hospital, Zhejiang, Hangzhou, P. R. China.
- School of Pharmacy, Anhui Medical University, Hefei, P. R. China.
ORCID-Profile: Huan Qiu
Förderung
- National Natural Science Foundation of China
- National Natural Science Foundation of China Youth Project
- Anhui Medical University
- Anhui Provincial Institute of Translational Medicine
Zitieren
APA
Wei, C., Liu, X., Hu, S., Shen, X., Liu, Y., Qin, X., Zhou, Y., Zheng, J., Tian, B., Hong, J., Song, Y., Wang, D., Peng, L., Ding, J., Wang, F., Zhang, H., Zhang, S., & Qiu, H. (2026). MEN1 Deficiency Drives Lung Cancer Progression via Activation of MMP10 ‐Mediated Angiogenesis. Cancer Science. https://doi.org/10.1111/cas.70470
Vancouver
Wei C, Liu X, Hu S, Shen X, Liu Y, Qin X, et al. MEN1 Deficiency Drives Lung Cancer Progression via Activation of MMP10 ‐Mediated Angiogenesis. Cancer Science. 2026. doi:10.1111/cas.70470
BibTeX
@article{Wei2026,
author = {Wei, Chengyu and Liu, Xiangyu and Hu, Shimin and Shen, Xiaodie and Liu, Yingli and Qin, Xinxin and Zhou, Ye and Zheng, Jianqi and Tian, Bingke and Hong, Jingfang and Song, Yongxia and Wang, Di and Peng, Linlin and Ding, Jinxia and Wang, Fang and Zhang, Hui and Zhang, Shihao and Qiu, Huan},
title = {MEN1 Deficiency Drives Lung Cancer Progression via Activation of MMP10 ‐Mediated Angiogenesis},
journal = {Cancer Science},
year = {2026},
doi = {10.1111/cas.70470}
}
EUVIMED